Stay updated on IDH-Targeted vs Non-Targeted Therapies in Newly Diagnosed AML Clinical Trial
Sign up to get notified when there's something new on the IDH-Targeted vs Non-Targeted Therapies in Newly Diagnosed AML Clinical Trial page.

Latest updates to the IDH-Targeted vs Non-Targeted Therapies in Newly Diagnosed AML Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision history now includes an entry for v3.4.2 and removes v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check15 days agoChange DetectedAdded Revision: v3.4.1; removed the government funding notice and Revision: v3.4.0 from the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check22 days agoChange DetectedAdded a banner notice about a lapse in government funding. It states that information may not be up to date and provides links for more details (cc.nih.gov and opm.gov).SummaryDifference0.7%

- Check29 days agoChange DetectedThe update adds a glossary option and color-coded change indicators (green for additions, red for deletions) and updates the revision label to v3.4.0, while removing the No FEAR Act data text.SummaryDifference1%

- Check36 days agoChange DetectedRecord History now includes Revision: v3.3.4 and removes Revision: v3.3.3. This indicates a recent update to the study record in the history section.SummaryDifference0.1%

- Check65 days agoChange DetectedNew Revision: v3.3.3 appears on the page history, and 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' have been removed from the footer. These are administrative site-wide updates rather than study details or the core content of the trial record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to IDH-Targeted vs Non-Targeted Therapies in Newly Diagnosed AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IDH-Targeted vs Non-Targeted Therapies in Newly Diagnosed AML Clinical Trial page.